Jaana Ronkainen
Overview
Explore the profile of Jaana Ronkainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koskela M, Ylinen E, Ukonmaanaho E, Autio-Harmainen H, Heikkila P, Lohi J, et al.
Pediatr Nephrol
. 2017 Feb;
32(7):1201-1209.
PMID: 28197887
Background: Histological findings from primary kidney biopsies were correlated with patient outcomes in a national cohort of paediatric Henoch-Schönlein nephritis (HSN) patients. Methods: Primary kidney biopsies from 53 HSN patients...
2.
Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al.
Pediatr Nephrol
. 2012 Feb;
27(6):933-9.
PMID: 22311342
Background: Corticosteroids have been shown not to prevent the development of Henoch-Schönlein nephritis. However, long-term follow-up data are scarce. Methods: The long-term outcome of patients in a randomized placebo-controlled prednisone...
3.
Jauhola O, Ronkainen J, Autio-Harmainen H, Koskimies O, Ala-Houhala M, Arikoski P, et al.
Pediatr Nephrol
. 2011 Jun;
26(12):2159-66.
PMID: 21626222
Knowledge about how to treat severe Henoch-Schönlein nephritis (HSN) is scarce. The aim of our study is to compare cyclosporine A (CyA) and methylprednisolone pulses (MP) in the treatment of...
4.
Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al.
Arch Dis Child
. 2010 Sep;
95(11):877-82.
PMID: 20852275
Objective: To assess the risk factors for developing Henoch-Schönlein purpura nephritis (HSN) and to determine the time period when renal involvement is unlikely after the initial disease onset. Design: A...
5.
Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al.
Arch Dis Child
. 2010 Apr;
95(11):871-6.
PMID: 20371584
Objective: To describe the extrarenal symptoms and clinical course of Henoch-Schönlein purpura (HSP). Design: A prospective national multicentre trial with 6-month follow-up. Patients A total of 223 newly diagnosed paediatric...
6.
Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Arikoski P, Jahnukainen T, et al.
Duodecim
. 2007 Sep;
123(11):1329-37.
PMID: 17763651
No abstract available.
7.
Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, et al.
J Pediatr
. 2006 Aug;
149(2):241-7.
PMID: 16887443
Objective: To evaluate the efficacy of early prednisone therapy in preventing renal and treating extrarenal and renal symptoms in Henoch-Schönlein purpura (HSP) in a placebo-controlled trial. Study Design: A total...
8.
Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Jahnukainen T, Koskimies O, Merenmies J, et al.
Pediatr Nephrol
. 2006 Jul;
21(9):1266-73.
PMID: 16838184
We evaluated the natural long-term outcome after childhood IgA nephritis. Altogether 55 patients with biopsy-proven IgA nephritis were identified, 37 (67%) responded to the health questionnaire and 31 (56%) participated...
9.
Ronkainen J, Autio-Harmainen H, Nuutinen M
Pediatr Nephrol
. 2003 Aug;
18(11):1138-42.
PMID: 12928858
We evaluated the efficacy of cyclosporin A (CyA) for treating pediatric patients with severe Henoch-Schönlein glomerulonephritis (HSP-GN) and nephrotic-range proteinuria. Seven pediatric HSP-GN patients (5 boys, 2 girls) were treated...
10.
Ronkainen J, Nuutinen M, Koskimies O
Lancet
. 2002 Sep;
360(9334):666-70.
PMID: 12241872
Background: Henoch-Schönlein purpura arising in childhood could cause renal impairment or even an end-stage renal disease later in life. We aimed to assess long-term outcome of childhood Henoch-Schönlein purpura after...